Specificity of Nef peptide-induced apoptosis to CXCR4. (A) MDA-MB-468 cultures were either untransfected or transiently transfected with a vector, CCR5, or CXCR4 cDNA clone. Bars 1 to 5 represent experiments performed on untransfected MDA-MB-468 cells, bars 6 to 10 represent experiments performed on Pc-Fusin (CXCR4)-transfected MDA-MB-468 cells, bars 11 to 14 represent experiments performed on pCR3.1-transfected MDA-MB-468 cells, and bars 15 to 18 represent experiments performed on CCR5-transfected MDA-MB-468 cells. At 48 h posttransfection, the cultures were treated for 24 h as follows: for bars 1, 6, 11, and 15, cells were treated with medium (UT); for bars 2, 7, 12, and 16, cells were treated with Nef protein (N; 4.3 nM); for bars 3, 8, 13, and 17, cells were treated with M1 (4.2 nM); for bars 4 and 9, cells were treated with the 20-mer peptide N130 (5.7 nM); and for bars 5, 10, 14, and 18, cells were treated with M2 (4.3 nM). In the graph, the y axis is shown on a log scale to allow viewing of the treatments that did not induce apoptosis. (B) Jurkat cell cultures were pretreated with medium (bars 1 to 4), SDF-1α (bars 5 to 8; 4.7 nM), CXCR4 antibody (bars 9 to 12; 5 μg/ml), CD4 antibody (bars 13 to 16; 10 ng/ml), CCR5 antibody (bars 17 to 20; 5 μg/ml), or vMIP-II (bars 21 to 24; 5.5 nM). Subsequently, a subset of those cultures were treated with medium (UT; bars 1, 5, 9, 13, 17, and 21), Nef protein (N; bars 2, 6, 10, 14, 18, and 22; 4.3 nM), M1 (bars 3, 7, 11, 15, 19, and 23; 4.2 nM), or M2 (bars 4, 8, 12, 16, 20, and 24; 4.3 nM). The error bars show the standard errors of the measurements, and the results are a compilation of at least three independent experiments.